Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Neelesh Sharma, MD
Vivace Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Monash Health
Clayton, Victoria, Australia
Recruiting - Peter Maccullum Cancer Centre
Melbourne, Victoria, Australia
Recruiting - Linear Clinical Research
Nedlands, Western Australia, Australia
Recruiting
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
Recruiting - University of Chicago Medical Center
Chicago, Illinois, United States
Recruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting - M Health Fairview University of Minnesota Medical Center
Minneapolis, Minnesota, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - Next Oncology
San Antonio, Texas, United States
Recruiting - Virginia Cancer Specialists, Pc
Arlington, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Mar 2021
- Primary completion
- 2 Nov 2029
- Completion
- 2 Mar 2030
- Last update posted
- 2 Apr 2026
- Registered enrollment
- 434
- Registry id
- NCT04665206
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.